The word “pill” was used more than 40 times in a single article in a medical journal about a New York hospital that refused to administer a lifesaving drug, according to an analysis by Bloomberg Politics.
In a piece published Monday, Bloomberg Politics reported that a drug company had sent an emergency memo to its hospitals warning them that they must administer “an emergency dose of [a] lifesaving medication” to patients who refuse to take the pill.
The FDA approved the drug, called lorazepam, in 2015, but some hospitals refused to take it.
Since then, more than 30 states have banned it and more than 200 hospitals have refused to follow their state’s laws.
“A major problem for hospitals and health care facilities has been the inability of the pharmaceutical industry to make the drug available for the many patients who are not willing to take [the drug],” said Dr. James F. Anderson, a professor of medicine at Harvard Medical School and author of The New Politics of Medicine.
“It’s been a big problem.
And now the FDA is trying to solve the problem.”
The problem has become so serious that several health care providers are starting to speak out.
Dr. David J. Felsenthal, a pediatric neurologist and an advocate for the drug in New York, said in an interview that he was “sickened” by the memo and told Bloomberg that he is planning to file a lawsuit.
“The whole situation in New England is very, very sad,” he said.
“They have been told not to give them [the drugs] by the FDA, but the FDA has never said they can’t give them to them.
So now they’re being told that it’s a free-for-all.”
I’m sickened by the way that this is happening,” he added.”
In the memo, the company says that the drugs are not required for patients who need them, which Felshaws said is “absolutely ludicrous.””
If a person is unwilling to take a lifesaver drug, then there are people out there who should not be able to go to work or to go out and live their lives.”
In the memo, the company says that the drugs are not required for patients who need them, which Felshaws said is “absolutely ludicrous.”
The FDA is expected to issue its final decision on whether to allow the drug to be dispensed by March 1.
A spokeswoman for the hospital declined to comment on the memo.
A spokesman for the New York State Department of Health did not respond to a request for comment.
Bloomberg News reported that the memo from the drug company, Pharmaprix, said that the hospital would be “required to make decisions that are inconsistent with the law, consistent with its legal obligations, or that would harm patients, and to provide appropriate and appropriate alternatives” to the drug.
The memo did not identify the hospital.
Felshees said he was surprised to learn that the FDA did not make the memo public, given the urgency of the situation.
“When you have a crisis like this, people will do whatever they can to make sure they can do something,” Felshes said.
“This is a very big problem for the whole of the country.
And I think we’re going to see a lot of these problems.
The FDA is in a very difficult situation.”
In addition to the lawsuit, Bloomberg News reported on Tuesday that doctors and health officials in New Hampshire, Massachusetts, Washington and New Jersey have filed lawsuits against drug makers and hospitals.